Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Sponsor

Conditions

Leukemia 9 Prostatic Neoplasms 7 Neuroblastoma 6 Leukemia, Myeloid, Acute 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Myelodysplastic Syndromes 5 Multiple Myeloma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Glioblastoma 5 Melanoma 4 Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Osteosarcoma 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tetanus 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡